{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:01:33Z","timestamp":1776124893996,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07931-3","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:05:22Z","timestamp":1772708722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prescribed benzodiazepines and suicidal behaviors: a systematic review, meta-analysis, and clinical implications"],"prefix":"10.1186","volume":"26","author":[{"given":"Zelfa","family":"Hamadieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narelle","family":"Ellendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"4","key":"7931_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, Cornett EM, Kaye AM, Kaye AD. Benzodiazepines: Uses, Dangers, and Clinical Considerations. Neurol Int. 2021;13(4):594\u2013607.","journal-title":"Neurol Int"},{"key":"7931_CR2","unstructured":"Bounds CGPP. Benzodiazepines. In. National Library of Medicine 2025 Jan."},{"issue":"2","key":"7931_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1176\/appi.ps.201800321","volume":"70","author":"DT Maust","year":"2019","unstructured":"Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv. 2019;70(2):97\u2013106.","journal-title":"Psychiatr Serv"},{"issue":"4","key":"7931_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996\u20132013. Am J Public Health. 2016;106(4):686\u20138.","journal-title":"Am J Public Health"},{"key":"7931_CR5","doi-asserted-by":"publisher","first-page":"1465245","DOI":"10.3389\/fphar.2024.1465245","volume":"15","author":"Z Su","year":"2024","unstructured":"Su Z, Huang Z, Chen X, Li X. Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database. Front Pharmacol. 2024;15:1465245.","journal-title":"Front Pharmacol"},{"issue":"38","key":"7931_CR6","doi-asserted-by":"publisher","first-page":"e30762","DOI":"10.1097\/MD.0000000000030762","volume":"101","author":"T El Zahran","year":"2022","unstructured":"El Zahran T, Kanaan E, Kobeissi L, Bouassi J, Sarieddine A, Carpenter J, Kazzi Z, Hitti E. Benzodiazepine use disorder: A cross-sectional study at a tertiary care center in Lebanon. Med (Baltim). 2022;101(38):e30762.","journal-title":"Med (Baltim)"},{"issue":"6","key":"7931_CR7","doi-asserted-by":"publisher","first-page":"e2317130","DOI":"10.1001\/jamanetworkopen.2023.17130","volume":"6","author":"J Lieslehto","year":"2023","unstructured":"Lieslehto J, Tiihonen J, L\u00e4hteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder. JAMA Netw Open. 2023;6(6):e2317130.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"7931_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jech.2006.055533","volume":"62","author":"DC Voaklander","year":"2008","unstructured":"Voaklander DC, Rowe BH, Dryden DM, Pahal J, Saar P, Kelly KD. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health. 2008;62(2):138\u201346.","journal-title":"J Epidemiol Community Health"},{"key":"7931_CR9","unstructured":"Stephen Liu P. Trends in nonfatal and fatal overdoses involving benzodiazepines \u2014 38 States and the District of Columbia, 2019\u20132020. 2021."},{"issue":"1","key":"7931_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1186\/s12889-020-09250-y","volume":"20","author":"T Ghosh","year":"2020","unstructured":"Ghosh T, Bol K, Butler M, Gabella B, Kingcade A, Kaplan G, Myers L. Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015\u20132017. BMC Public Health. 2020;20(1):1149.","journal-title":"BMC Public Health"},{"key":"7931_CR11","doi-asserted-by":"crossref","unstructured":"Br\u00e5dvik L, L\u00f6wenhielm P, Frank A, Berglund M. From substance use disorders in life to autopsy findings: a combined case-record and medico-legal study. Int J Environ Res Public Health 2019, 16(5).","DOI":"10.3390\/ijerph16050801"},{"issue":"6","key":"7931_CR12","first-page":"438","volume":"36","author":"L Algarrada Vico","year":"2024","unstructured":"Algarrada Vico L, Mart\u00ednez-S\u00e1nchez L, Baena Olom\u00ed I, Benito Cald\u00e9s C, Rodr\u00edguez Varela A, L\u00f3pez-Corominas V, Gaitero Trist\u00e1n J, Mangione Cardarella L, Pe\u00f1alba C\u00edtores A, Mu\u00f1oz Bernal J, et al. Multicenter study of adolescent suicide attempts by poisoning: social, epidemiological, and clinical characteristics. Emergencias. 2024;36(6):438\u201346.","journal-title":"Emergencias"},{"issue":"1","key":"7931_CR13","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1186\/s12889-024-19095-4","volume":"24","author":"L Tu","year":"2024","unstructured":"Tu L, Liu Y, Zhu H, Zhang Q, Ji X. Characteristics of drug overdose suicide attempts presenting to the psychiatric emergency department of Beijing Anding Hospital. BMC Public Health. 2024;24(1):1597.","journal-title":"BMC Public Health"},{"issue":"1","key":"7931_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12888-019-2015-9","volume":"19","author":"IK Gravensteen","year":"2019","unstructured":"Gravensteen IK, Ekeberg \u00d8, Thiblin I, Helweg-Larsen K, Hem E, Rogde S, T\u00f8llefsen IM. Psychoactive substances in natural and unnatural deaths in Norway and Sweden - a study on victims of suicide and accidents compared with natural deaths in psychiatric patients. BMC Psychiatry. 2019;19(1):33.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"7931_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/00952990.2022.2053981","volume":"48","author":"MJ Seamans","year":"2022","unstructured":"Seamans MJ, Mays VM, Arseniev-Koehler A, Cochran SD. Prevalence of prescription and illicit drugs in suicides by non-poisoning means in the National Violent Death Reporting System 2003\u20132017. Am J Drug Alcohol Abuse. 2022;48(4):464\u201370.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"7931_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0165-1781(97)00060-7","volume":"71","author":"GN Pandey","year":"1997","unstructured":"Pandey GN, Conley RR, Pandey SC, Goel S, Roberts RC, Tamminga CA, Chute D, Smialek J. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Res. 1997;71(3):137\u201349.","journal-title":"Psychiatry Res"},{"issue":"8","key":"7931_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopsych.2008.05.028","volume":"64","author":"MO Poulter","year":"2008","unstructured":"Poulter MO, Du L, Weaver ICG, Palkovits M, Faludi G, Merali Z, Szyf M, Anisman H. GABA\u2009<\u2009sub>A Receptor Promoter Hypermethylation in Suicide Brain: Implications for the Involvement of Epigenetic Processes. Biol Psychiatry. 2008;64(8):645\u201352.","journal-title":"Biol Psychiatry"},{"key":"7931_CR18","doi-asserted-by":"crossref","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction 2011, 106(12):2086\u2013109.","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"issue":"9","key":"7931_CR19","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00127-013-0675-1","volume":"48","author":"D Gunnell","year":"2013","unstructured":"Gunnell D, Chang S-S, Tsai MK, Tsao CK, Wen CP. Sleep and suicide: an analysis of a cohort of 394,000 Taiwanese adults. Soc Psychiatry Psychiatr Epidemiol. 2013;48(9):1457\u201365.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"10","key":"7931_CR20","first-page":"917","volume":"30","author":"A Kanwar","year":"2013","unstructured":"Kanwar A, Malik S, Prokop LJ, Sim LA, Feldstein D, Wang Z, Murad MH. THE ASSOCIATION BETWEEN ANXIETY DISORDERS AND SUICIDAL BEHAVIORS: A SYSTEMATIC REVIEW AND META-ANALYSIS. Depress Anxiety. 2013;30(10):917\u201329.","journal-title":"Depress Anxiety"},{"key":"7931_CR21","doi-asserted-by":"crossref","unstructured":"Rothschild AJ, Shindul-Rothschild JA. Benzodiazepines do not cause suicide or suicide attempts. prim care companion CNS Disord 2017, 19(5).","DOI":"10.4088\/PCC.17lr02171"},{"issue":"5","key":"7931_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000524400","volume":"91","author":"SL Dubovsky","year":"2022","unstructured":"Dubovsky SL, Marshall D. Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice. Psychother Psychosom. 2022;91(5):307\u201334.","journal-title":"Psychother Psychosom"},{"issue":"3","key":"7931_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/acps.13582","volume":"148","author":"M Tournier","year":"2023","unstructured":"Tournier M, B\u00e9nard-Laribi\u00e8re A, Jollant F, Hucteau E, Diop P-Y, Jarne-Munoz A, Pariente A, Oger E, Bezin J. Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study. Acta psychiatrica Scandinavica. 2023;148(3):233\u201341.","journal-title":"Acta psychiatrica Scandinavica"},{"key":"7931_CR24","doi-asserted-by":"publisher","first-page":"109046","DOI":"10.1016\/j.drugalcdep.2021.109046","volume":"228","author":"RD Gibbons","year":"2021","unstructured":"Gibbons RD, Hur K, Quinn PD. Concomitant opioid and benzodiazepine use and risk of suicide attempt and intentional self-harm: Pharmacoepidemiologic study. Drug Alcohol Depend. 2021;228:109046.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7931_CR25","first-page":"22746","volume":"19","author":"TJ Dodds","year":"2017","unstructured":"Dodds TJ. Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. Prim Care Companion CNS Disorders. 2017;19(2):22746.","journal-title":"Prim Care Companion CNS Disorders"},{"issue":"5","key":"7931_CR26","first-page":"e84318","volume":"17","author":"Khan","year":"2025","unstructured":"Khan SMA. Suicidal ideation and suicide completion in benzodiazepine Users: A systematic review of current evidence. Cureus. 2025;17(5):e84318. May 18.","journal-title":"Cureus"},{"key":"7931_CR27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"7931_CR28","doi-asserted-by":"crossref","unstructured":"Hamadieh Z. Prescribed Benzodiazepines and Suicidal Behaviors: A Systematic Review, Meta-Analysis, and Clinical Implications. 2025.","DOI":"10.1186\/s12888-026-07931-3"},{"key":"7931_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.genhosppsych.2019.11.005","volume":"62","author":"JM Boggs","year":"2020","unstructured":"Boggs JM, Lindrooth RC, Battaglia C, Beck A, Ritzwoller DP, Ahmedani BK, Rossom RC, Lynch FL, Lu CY, Waitzfelder BE, et al. Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2020;62:21\u20137.","journal-title":"Gen Hosp Psychiatry"},{"key":"7931_CR30","doi-asserted-by":"crossref","unstructured":"Guina J, Nahhas RW, Mata N, Farnsworth S. Which posttraumatic stress disorder symptoms, trauma types, and substances correlate with suicide attempts in trauma survivors? prim care companion CNS Disord 2017, 19(5).","DOI":"10.4088\/PCC.17m02177"},{"issue":"5","key":"7931_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.5664\/jcsm.9096","volume":"17","author":"AS Tubbs","year":"2021","unstructured":"Tubbs AS, Fernandez FX, Ghani SB, Karp JF, Patel SI, Parthasarathy S, Grandner MA. Prescription medications for insomnia are associated with suicidal thoughts and behaviors in two nationally representative samples. J Clin Sleep Med. 2021;17(5):1025\u201330.","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"7931_CR32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12888-019-2312-3","volume":"19","author":"V Cato","year":"2019","unstructured":"Cato V, Holl\u00e4ndare F, Nordenskj\u00f6ld A, Sellin T. Association between benzodiazepines and suicide risk: a matched case-control study. BMC Psychiatry. 2019;19(1):317.","journal-title":"BMC Psychiatry"},{"key":"7931_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpsychires.2021.04.006","volume":"138","author":"A Demesmaeker","year":"2021","unstructured":"Demesmaeker A, Chazard E, Vaiva G, Amad A. A pharmacoepidemiological study of the association of suicide reattempt risk with psychotropic drug exposure. J Psychiatr Res. 2021;138:256\u201363.","journal-title":"J Psychiatr Res"},{"key":"7931_CR34","doi-asserted-by":"crossref","unstructured":"Deka R, Bryan CJ, LaFleur J, Oderda G, Atherton A, Stevens V. Benzodiazepines, Health care utilization, and suicidal behavior in veterans with posttraumatic stress disorder. J Clin Psychiatry 2018, 79(6).","DOI":"10.4088\/JCP.17m12038"},{"issue":"1","key":"7931_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1513\/AnnalsATS.201802-145OC","volume":"16","author":"LM Donovan","year":"2019","unstructured":"Donovan LM, Malte CA, Spece LJ, Griffith MF, Feemster LC, Engelberg RA, Au DH, Hawkins EJ. Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder. Ann Am Thorac Soc. 2019;16(1):82\u201390.","journal-title":"Ann Am Thorac Soc"},{"key":"7931_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291724002873","volume":"54","author":"MF Str\u00f8mme","year":"2024","unstructured":"Str\u00f8mme MF, Thue Augustsson M, Bartz-Johannessen C, Stautland A, Mykletun A, Kroken RA, Mehlum L, Kjelby E, Johnsen E. Suicidality and use of psychotropic medications in patients with schizophrenia: a prospective cohort study. Psychol Med. 2024;54:1\u20139.","journal-title":"Psychol Med"},{"key":"7931_CR37","doi-asserted-by":"publisher","first-page":"115857","DOI":"10.1016\/j.psychres.2024.115857","volume":"335","author":"RD Gibbons","year":"2024","unstructured":"Gibbons RD, Hur K, Lavigne JE, Mann JJ. Risk of suicide attempts and intentional self-harm on alprazolam. Psychiatry Res. 2024;335:115857.","journal-title":"Psychiatry Res"},{"issue":"1","key":"7931_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40360-025-00858-7","volume":"26","author":"WL Xie","year":"2025","unstructured":"Xie WL, Xiang DC, Li YY, Ge ML, Deng AP. An exploratory study evaluating the 20 medications most commonly associated with suicidal ideation and self-injurious behavior in the FAERS database. BMC Pharmacol Toxicol. 2025;26(1):24.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"7931_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10461-023-04164-3","volume":"28","author":"A Smith","year":"2024","unstructured":"Smith A, Goulet JL, Vlahov D, Justice AC, Womack JA. Risk factors for suicide among veterans living with and without HIV: a nested case-control study. AIDS Behav. 2024;28(1):115\u201324.","journal-title":"AIDS Behav"},{"issue":"6","key":"7931_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","volume":"173","author":"J Tiihonen","year":"2015","unstructured":"Tiihonen J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, Tanskanen A. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. Am J Psychiatry. 2015;173(6):600\u20136.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"7931_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/00912174231162477","volume":"58","author":"P Narindrarangkura","year":"2023","unstructured":"Narindrarangkura P, Alafaireet PE, Khan U, Kim MS. Predicting suicide attempts among people with diabetes using a large multicenter electronic health records dataset. Int J Psychiatry Med. 2023;58(4):302\u201324.","journal-title":"Int J Psychiatry Med"},{"key":"7931_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2018.01.018","volume":"100","author":"H Lee","year":"2018","unstructured":"Lee H, Myung W, Lee C, Choi J, Kim H, Carroll BJ, Kim DK. Clinical epidemiology of long-term suicide risk in a nationwide population-based cohort study in South Korea. J Psychiatr Res. 2018;100:47\u201355.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"7931_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/02698811241309619","volume":"39","author":"N Kj\u00e6r H\u00f8ier","year":"2025","unstructured":"Kj\u00e6r H\u00f8ier N, Madsen T, Spira AP, Hawton K, Jennum P, Nordentoft M, Erlangsen A. Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study. J Psychopharmacol. 2025;39(2):121\u201331.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"7931_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","volume":"69","author":"J Tiihonen","year":"2012","unstructured":"Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry. 2012;69(5):476\u201383.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"7931_CR45","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1038\/s41598-024-57909-y","volume":"14","author":"F Huang","year":"2024","unstructured":"Huang F, San X, Liu Q, Zhu H, Xu W. Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database. Sci Rep. 2024;14(1):7489.","journal-title":"Sci Rep"},{"key":"7931_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jad.2024.10.028","volume":"369","author":"EA Abel","year":"2025","unstructured":"Abel EA, Travaglini LE, Snow JL, Goulet JL. The association of pain screening and pain level with suicide among US veterans with comorbid musculoskeletal and bipolar disorder diagnoses. J Affect Disord. 2025;369:429\u201335.","journal-title":"J Affect Disord"},{"issue":"8","key":"7931_CR47","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1047-2797(97)00126-9","volume":"7","author":"CI Neutel","year":"1997","unstructured":"Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and\/or antidepressant use. Ann Epidemiol. 1997;7(8):568\u201374.","journal-title":"Ann Epidemiol"},{"issue":"3","key":"7931_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"2","key":"7931_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","volume":"1","author":"M Borenstein","year":"2010","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97\u2013111.","journal-title":"Res Synth Methods"},{"issue":"7414","key":"7931_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"key":"7931_CR51","unstructured":"Thomas J, Higgins JPT, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5 (updated August 2024). London: Cochrane; 2024."},{"issue":"2","key":"7931_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11(2):193\u2013206.","journal-title":"Psychol Methods"},{"key":"7931_CR53","doi-asserted-by":"crossref","unstructured":"Critical interpretation of Cochran\u2019s Q test depends on power and prior assumptions about heterogeneity. In., vol. 1. US: John Wiley & Sons. 2010: 149\u2013161.","DOI":"10.1002\/jrsm.13"},{"issue":"7109","key":"7931_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629.","journal-title":"BMJ"},{"issue":"10","key":"7931_CR55","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/0006-3223(92)90181-X","volume":"32","author":"T Rochet","year":"1992","unstructured":"Rochet T, Kopp N, Vedrinne J, Deluermoz S, Debilly G, Miachon S. Benzodiazepine binding sites and their modulators in hippocampus of violent suicide victims. Biol Psychiatry. 1992;32(10):922\u201331.","journal-title":"Biol Psychiatry"},{"key":"7931_CR56","doi-asserted-by":"crossref","unstructured":"Hans-Gert B, Anne T, Rebecca W, Johann S, Patrick S, Martin W, Henrik D, Bernhard B. Disruption of Glutamate-Glutamine-GABA Cycle Significantly Impacts on Suicidal Behaviour: Survey of the Literature and Own Findings on Glutamine Synthetase. CNS & Neurological Disorders - Drug Targets 2013, 12(7):900\u2013913.","DOI":"10.2174\/18715273113129990091"},{"issue":"1","key":"7931_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","volume":"90","author":"SC Licata","year":"2008","unstructured":"Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008;90(1):74\u201389.","journal-title":"Pharmacol Biochem Behav"},{"key":"7931_CR58","first-page":"416864","volume":"2012","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, Olivier B. Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators? Adv Pharmacol Sci. 2012;2012:416864.","journal-title":"Adv Pharmacol Sci"},{"issue":"1","key":"7931_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-3565(25)20999-5","volume":"246","author":"LG Miller","year":"1988","unstructured":"Miller LG, Greenblatt DJ, Roy RB, Summer WR, Shader RI. Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function. J Pharmacol Exp Ther. 1988;246(1):177\u201382.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"7931_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1471-4159.1987.tb03407.x","volume":"49","author":"W Loscher","year":"1987","unstructured":"Loscher W, Schmidt D. Diazepam Increases \u03b3-Aminobutyric Acid in Human Cerebrospinal Fluid. J Neurochem. 1987;49(1):152\u20137.","journal-title":"J Neurochem"},{"issue":"4","key":"7931_CR61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jpsychires.2008.04.004","volume":"43","author":"R Lee","year":"2009","unstructured":"Lee R, Petty F, Coccaro EF. Cerebrospinal fluid GABA concentration: Relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res. 2009;43(4):353\u20139.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7931_CR62","doi-asserted-by":"crossref","first-page":"s99","DOI":"10.1111\/j.1365-2125.1981.tb01113.x","volume":"11","author":"RC Hall","year":"1981","unstructured":"Hall RC, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol. 1981;11(1):s99\u2013104.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"7931_CR63","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1192\/pb.26.12.460","volume":"26","author":"C Paton","year":"2002","unstructured":"Paton C. Benzodiazepines and disinhibition: a review. Psychiatr Bull. 2002;26(12):460\u20132.","journal-title":"Psychiatr Bull"},{"key":"7931_CR64","doi-asserted-by":"publisher","unstructured":"Sa\u00efas T, Gallarda T. Paradoxical aggressive reactions under benzodiazepines: a review of the literature. L'Enc\u00e9phale. 2008;34(4):330\u2013336. https:\/\/doi.org\/10.1016\/j.encep.2007.05.005","DOI":"10.1016\/j.encep.2007.05.005"},{"key":"7931_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-244X-7-42","volume":"7","author":"DF Kripke","year":"2007","unstructured":"Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7:42.","journal-title":"BMC Psychiatry"},{"key":"7931_CR66","doi-asserted-by":"publisher","first-page":"918","DOI":"10.12688\/f1000research.8729.1","volume":"5","author":"DF Kripke","year":"2016","unstructured":"Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res. 2016;5:918.","journal-title":"F1000Res"},{"issue":"12","key":"7931_CR67","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2013will we ever learn? Addiction. 2011;106(12):2086\u2013109.","journal-title":"Addiction"},{"issue":"Suppl 2","key":"7931_CR68","first-page":"28","volume":"66","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66(Suppl 2):28\u201333.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"7931_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","volume":"6","author":"A Schmitz","year":"2016","unstructured":"Schmitz A. Benzodiazepine use, misuse, and abuse: A review. Ment Health Clin. 2016;6(3):120\u20136.","journal-title":"Ment Health Clin"},{"key":"7931_CR70","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders (5th ed). (2013)."},{"key":"7931_CR71","unstructured":"(CDC) CfDCaP. List of all valid ICD 10 Codes, 1999\u20132023. In.: Centers for Disease Control and Prevention (CDC); 2024."},{"issue":"11","key":"7931_CR72","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1177\/0004867416644980","volume":"50","author":"V Starcevic","year":"2016","unstructured":"Starcevic V. The importance of distinguishing between dependence and addiction in the context of long-term benzodiazepine use. Aust N Z J Psychiatry. 2016;50(11):1111\u20132.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"7931_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0740-5472(91)90028-9","volume":"8","author":"NS Miller","year":"1991","unstructured":"Miller NS, Mahler JC. Addiction to and dependence on benzodiazepines: Diagnostic confusion in clinical practice and research studies. J Subst Abuse Treat. 1991;8(1):61\u20137.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"7931_CR74","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0924-9338(96)80312-9","volume":"10","author":"SM Linsen","year":"1995","unstructured":"Linsen SM, Zitman FG, Breteler MHM. Defining benzodiazepine dependence: the confusion persists. Eur Psychiatry. 1995;10(6):306\u201311.","journal-title":"Eur Psychiatry"},{"issue":"2","key":"7931_CR75","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Benzodiazepine Use in the United States. JAMA Psychiatry. 2015;72(2):136\u201342.","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"7931_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","volume":"18","author":"G Airagnes","year":"2016","unstructured":"Airagnes G, Pelissolo A, Lavall\u00e9e M, Flament M, Limosin F. Benzodiazepine Misuse in the Elderly: Risk Factors, Consequences, and Management. Curr Psychiatry Rep. 2016;18(10):89.","journal-title":"Curr Psychiatry Rep"},{"issue":"11","key":"7931_CR77","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/jamainternmed.2018.2413","volume":"178","author":"LB Gerlach","year":"2018","unstructured":"Gerlach LB, Maust DT, Leong SH, Mavandadi S, Oslin DW. Factors Associated With Long-term Benzodiazepine Use Among Older Adults. JAMA Intern Med. 2018;178(11):1560\u20132.","journal-title":"JAMA Intern Med"},{"issue":"11","key":"7931_CR78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 2013;27(11):967\u201371.","journal-title":"J Psychopharmacol"},{"issue":"4","key":"7931_CR79","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1176\/appi.ajp.161.4.654","volume":"161","author":"M Valenstein","year":"2004","unstructured":"Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC. Benzodiazepine Use Among Depressed Patients Treated in Mental Health Settings. Am J Psychiatry. 2004;161(4):654\u201361.","journal-title":"Am J Psychiatry"},{"key":"7931_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.genhosppsych.2019.11.005","volume":"62","author":"JM Boggs","year":"2020","unstructured":"Boggs JM, Lindrooth RC, Battaglia C, Beck A, Ritzwoller DP, Ahmedani BK, Rossom RC, Lynch FL, Lu CY, Waitzfelder BE, et al. Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2020;62:21\u20137.","journal-title":"Gen Hosp Psychiatry"},{"key":"7931_CR81","unstructured":"Administration UFD. Alprazolam Medication Label. 2023."},{"key":"7931_CR82","first-page":"1","volume-title":"CDC Guideline for Prescribing Opioids for Chronic Pain \u2014 United States, 2016","author":"DH Dowell","year":"2016","unstructured":"Dowell DH, Chou TM. R.: CDC Guideline for Prescribing Opioids for Chronic Pain \u2014 United States, 2016. Volume 65. Atlanta, GA: Centers for Disease Control and Prevention; 2016. pp. 1\u201349."},{"issue":"3","key":"7931_CR83","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s11606-020-06253-8","volume":"35","author":"K Mackey","year":"2020","unstructured":"Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Benefits and Harms of Long-term Opioid Dose Reduction or Discontinuation in Patients with Chronic Pain: a Rapid Review. J Gen Intern Med. 2020;35(3):935\u201344.","journal-title":"J Gen Intern Med"},{"key":"7931_CR84","unstructured":"FDA Identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual. Individualized Tapering [ https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes"},{"issue":"5","key":"7931_CR85","doi-asserted-by":"publisher","first-page":"e0232538","DOI":"10.1371\/journal.pone.0232538","volume":"15","author":"PORC Coffin","year":"2020","unstructured":"Coffin PORC, Oman N, Sinchek K, Santos G-M, Faul M, et al. Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain. PLoS ONE. 2020;15(5):e0232538.","journal-title":"PLoS ONE"},{"issue":"12","key":"7931_CR86","doi-asserted-by":"publisher","first-page":"e2348557","DOI":"10.1001\/jamanetworkopen.2023.48557","volume":"6","author":"DT Maust","year":"2023","unstructured":"Maust DT, Petzold K, Strominger J, Kim HM, Bohnert ASB. Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine Therapy. JAMA Netw Open. 2023;6(12):e2348557.","journal-title":"JAMA Netw Open"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07931-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07931-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:03:34Z","timestamp":1776081814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07931-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7931"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07931-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis based on previously published studies and does not involve primary data collection with human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"303"}}